Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Concomitant Presence of Jak2 V617f Mutation and Bcr-Abl Translocation in a Pregnant Woman With Polycythemia Vera Publisher Pubmed



Toogeh G1 ; Ferdowsi S2 ; Naadali F3 ; Alimoghaddam K4 ; Ghavamzadeh A4 ; Shirkoohi R5 ; Ghaffari SH4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology-Oncology and BMT Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Hematology, Molecular Genetics, Cancer Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Pathology Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Hematology-Oncology and BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran 11411, Kargar Street, Iran
  5. 5. Molecular Genetics, Cancer Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: Medical Oncology Published:2011


Abstract

In 2007, a 27-year-old woman presented with mild splenomegaly. Blood counts showed hemoglobin (Hb): 17.8 g/dl, HCT: 56% and Red blood cells: 6.45 × 10 12/L. Bone marrow examination disclosed a hypercellular marrow. Molecular analysis showed the presence of the JAK2 V617F mutation and BCR-ABL/BCR mRNA b3a2 transcript. A diagnosis of BCR-ABL-positive polycythemia vera (PV) was made. In 2009, she had nulipar pregnancy and treated with interferon-alpha. She delivered a healthy girl infant at 37 weeks. This case report suggests that in a PV pregnant woman with a concomitant presence of JAK2 V617F mutation and BCR-ABL translocation, the administration of interferon during the pregnancy could lead to a safe pregnancy and delivery. © 2010 Springer Science+Business Media, LLC.